Subsequently, in a large cohort of patients with diagnosed NSCLC, Nair and colleagues found that Nuclear factor-κB (NF-κB) IHC expression was related to tumour metabolism, measured using FDG-PET, and prognosis provided a methodology for studying tumour biology using computational approaches [146]. Here, NFKB1 is linked to non-small cell lung carcinoma.